Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure

BACKGROUND: Tolvaptan, a vasopressin V(2) receptor blocker, has a diuretic effect for patients with heart failure. However, there were a few data concerning the effects of tolvaptan in patients with chronic kidney disease (CKD). METHODS: We retrospectively analyzed 21 patients with chronic heart fai...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Exp Nephrol
Asıl Yazarlar: Katsumata, Mari, Hirawa, Nobuhito, Sumida, Koichiro, Kagimoto, Minako, Ehara, Yosuke, Okuyama, Yuki, Fujita, Megumi, Fujiwara, Akira, Kobayashi, Mayumi, Kobayashi, Yusuke, Yamamoto, Yuichiro, Saka, Sanae, Yatsu, Keisuke, Fujikawa, Tetsuya, Toya, Yoshiyuki, Yasuda, Gen, Tamura, Kouichi, Umemura, Satoshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Japan 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5648735/
https://ncbi.nlm.nih.gov/pubmed/28190113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-016-1379-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller